Outcomes of Therapist-led Online Cancer Bereavement Groups
Trial completed
University College, LondonNot applicable NCT07002424 Registry history of NCT07002424 on ClinicalTrials.gov (opens the registry)
Updated
4 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 4 with minor changes only.
Trial completed
University College, LondonNot applicable NCT07002424 Registry history of NCT07002424 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
University College, LondonNot applicable NCT06409806 Registry history of NCT06409806 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2023); last known: Not Yet Recruiting
University College, LondonNot specified NCT06035107 Registry history of NCT06035107 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
University College, LondonNot applicable NCT04571840 Registry history of NCT04571840 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-21 | NCT07831902 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO)… | Phase 3 | Recruiting |
| Early Phase 1 | 1 | |
| Phase 1 | 12 | |
| Phase 1/2 | 5 | |
| Phase 2 | 19 | |
| Phase 2/3 | 2 | |
| Phase 3 | 19 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07831902 | Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO)… | Endometrial Cancer | Recruiting | 2026-09-21 |
| NCT07751133 | Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer | Prostate Cancer | Recruiting | 2026-09-04 |
| NCT07724132 | An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic… | Alzheimer's Disease (AD) | Recruiting | 2026-07-23 |
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | Hodgkin Lymphoma | Recruiting | 2026-07-08 |
| NCT07207057 | Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm… | Parkinsons Disease (PD) | Recruiting | 2025-10-03 |
| NCT06320067 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive… | Prostate Cancer Metastatic | Recruiting | 2025-09-26 |
| NCT05778617 | Ambroxol to Slow Progression in Parkinson Disease | Parkinson Disease | Recruiting | 2025-05-01 |
| NCT05405868 | Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase… | Glaucoma, Open-Angle | Recruiting | 2024-05-09 |
| NCT03288532 | Renal Adjuvant MultiPle Arm Randomised Trial | Renal Cell Carcinoma | Recruiting | 2020-09-07 |
| NCT07813351 | PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy… | Acromegaly Due to Pituitary Adenoma | Not Yet Recruiting | 2026-10-01 |
| NCT07792096 | An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and… | HIV Infection | Not Yet Recruiting | 2026-08-28 |
| NCT07726693 | Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial | Liver Cirrhosis | Not Yet Recruiting | 2026-07-24 |
| NCT07163143 | Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed… | Tuberculosis (TB) | Not Yet Recruiting | 2025-09-09 |
| NCT02804815 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival… | Cancer | Active, Not Recruiting | 2025-06-10 |
| NCT05073835 | Semaglutide 2.4 mg in Patients With Poor Weight-loss | Obesity | Active, Not Recruiting | 2024-12-06 |
| NCT01566240 | Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced… | Cervical Cancer | Active, Not Recruiting | 2024-12-05 |
| NCT06242782 | Vertical Ridge Augmentation Strategies | Alveolar Bone Resorption | Not Yet Recruiting | 2024-02-05 |
| NCT00943423 | PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage… | Lymphoma | Active, Not Recruiting | 2023-11-30 |
| NCT02544308 | Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma | Plasmacytoma | Active, Not Recruiting | 2022-12-23 |
| Phase 2/3 | ||||
| NCT04061512 | Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC)… | Waldenstrom Macroglobulinemia | Recruiting | 2024-05-10 |
| NCT01398085 | IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer… | Thyroid Cancer | Active, Not Recruiting | 2026-05-07 |
| Phase 2 | ||||
| NCT06114628 | Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB | Pulmonary Tuberculosis | Recruiting | 2026-10-15 |
| NCT07202949 | A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With… | Chronic Urinary Tract Infection | Recruiting | 2026-10-14 |
| NCT06762769 | Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma | Smouldering Myeloma | Recruiting | 2025-08-01 |
| NCT05635162 | Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma | Mantle Cell Lymphoma | Recruiting | 2025-04-16 |
Prostate Cancer (15) · Lung Cancer (7) · Head & Neck Cancer (6) · Leukemia (6) · Acute Lymphoblastic Leukemia (ALL) (5) · Dementia (5) · Epilepsy (5) · Heart Disease (5) · Non-Hodgkin Lymphoma (5) · Stroke (5)